Studying the effects of polycyclic aromatic hydrocarbons on peripheral arterial disease in the United States.

Xiaohui Xu,Hui Hu,Gregory D Kearney,Haidong Kan,David S Sheps
DOI: https://doi.org/10.1016/j.scitotenv.2013.04.089
2013-01-01
Abstract:•This study used urinary biomarkers, i.e. metabolites of PAHs, as objective measurements of exposure.•The effects of PAHs on peripheral arterial disease (PAD) were examined among a large population-based sample.•Our study for the first time suggests that exposure to PAHs may increase the risk of PAD independent of smoking.
What problem does this paper attempt to address?